REGULATORY INTELLIGENCE·Recall
IntegraDose Vasopressin Recall: Sub-Potency Exposes Minnesota Healthcare Providers to Supply Risk and Regulatory Scrutiny
IntegraDose Compounding Services LLC has initiated a Class II recall for 1,299 syringes of Vasopressin due to sub-potency, failing to maintain strength through its expiration date. This event, coupled with a prior Fentanyl Citrate recall, signals systemic quality control issues. Procurement and regulatory teams must assess immediate supply chain risks for compounded drugs in Minnesota and scrutinize IntegraDose's compliance trajectory.
90-Day Activity